The Coalition to
Protect Patient Choice

A Project
of the
Law Offices
of David Balto
Competitive healthcare is healthcare with choices
Advocacy on consumer healthcare competition issues aimed at lowering prescription drug costs
Testimony
David Balto, Statement testimony before the House Oversight and Government Reform Committee on Developments in the Prescription Drug Market, February 4, 2016
David Balto, Testimony before the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law on the state of competition in the Pharmacy Benefits Manager and Pharmacy Marketplaces, November 17, 2015
Lynn Quincy, Consumers Union, Testimony before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law, November 17, 2015
David Balto, Testimony before the Department of Labor on the benefits of PBM transparency, June 19, 2014
Lynn Quincy, Consumers Union, Testimony before the Department of Labor on the benefits of PBM transparency, June 19, 2014
Randy DeFrehn, National Coordinating Committee for Multi-employer Plans, Testimony before the Department of Labor on the benefits of PBM transparency, June 19, 2014
Joe Baker, Testimony before the Energy & Commerce Committee, Subcommittee on Health, February 26, 2014
David Balto, Testimony before the North Dakota Legislature on PBM MAC legislation, March 25, 2013
Letters
FTC Commissioner Julie Brill, Letter to the ERISA Advisory Council of the Department of Labor disputing FTC Staff opinion that PBM market is competitive, August 19, 2014
Report urging more oversight of PBMs, Center for Medicare and Medicaid Services
David Balto, Letter to the Hawaii Legislature on anti-mail order legislation, April 12, 2013
Comments
David Balto, Comments to the FTC/DOJ Healthcare Workshop discussing the effects of PBMs' restrictive pharmacy networks on patients and specialty pharmacies, April 30, 2015.
Increasing Competition and Choice: An Evaluation of Proposed Medicare Regulation and Their Impact on Pharmaceutical Access and Care, David Balto and James Kovaks
Competitive Concerns and Price Transparency in the PBM Market, David Balto
The Cost of PBM "Self-Dealing" Under a Medicare Prescription Drug Benefit, James Langenfeld and Robert Maness
Leveling the Playing Field in the Pharmacy Benefit Management Industry, Allison Dabbs Garrett and Robert Garis
Squeezing the Middleman: Ending Underhanded Dealing in the Pharmacy Benefit Management Industry through Regulation, Mark Meador
The Need for Transparency in Health Care: Clearing the Fog to Make the Market Work, David Balto